Litcius/Paper detail

Cereblon E3 Ligase Modulators Mezigdomide and Iberdomide in Multiple Myeloma

Tanvi H Patel, Frits van Rhee, Samer Al Hadidi

2024Clinical Lymphoma Myeloma & Leukemia12 citationsDOI

Topics & Concepts

PomalidomideMedicineMultiple myelomaLenalidomideCereblonBlinatumomabClinical trialImmunologyOncologyInternal medicineAntibodyUbiquitin ligaseBiologyGeneBiochemistryUbiquitinCD19Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsPeptidase Inhibition and Analysis
Cereblon E3 Ligase Modulators Mezigdomide and Iberdomide in Multiple Myeloma | Litcius